Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

The circulating lipidome in severe obesity.

Created on 20 Oct 2026

Authors

Mohammad Yaser Anwar, Heather M Highland, Alexandra B Palmer, Thy Duong, Zhaotong Lin, Wanying Zhu, Jessica Sprinkles, Daeeun Kim, Kristin L Young, Hung-Hsin Chen, Mohanraj Krishnan, Absalon Gutierrez, Rashedeh Roshani, Elizabeth G Frankel, Joshua Landman, Penny Gordon-Larsen, Susan K Fried, Miryoung Lee, Susan P Fisher-Hoch, Joseph B McCormick, Joanne Curran, John Blangero, Peter J Meikle, Corey Giles, Jennifer E Below, Kari E North, Mariaelisa Graff

Published in

iScience. Volume 29. Issue 11. Pages 117801. Nov 20, 2026. Epub Oct 08, 2026.

Abstract

Severe obesity (SevO; BMI ≥ 40 kg/m2) is rising globally yet remains understudied mechanistically. To characterize lipidomic alterations at the species level, we analyzed Border Health Research Cohort participants with fasting plasma lipidomics and genetic data, comparing SevO (n = 185) to non-obese controls (18.5 ≥ BMI < 25; n = 393). We quantified 830 lipid species across 49 classes and assessed associations using logistic regression, orthogonal projections to latent structures discriminant analysis (OPLS-DA), and network deconvolution Mendelian randomization (NDMR). SevO participants showed more adverse cardiometabolic traits. Lipidomics revealed broad dysregulation: shorter, saturated, and monounsaturated triacylglycerols were elevated in individuals living with SevO compared to controls, while lysophospholipids, plasmalogens, cholesteryl esters, and long-chain species were reduced. OPLS-DA identified over 300 lipids strongly predictive of SevO, and NDMR implicated specific triacylglycerols as potentially contributing to SevO status. Influential lipids correlated with insulin resistance, liver fat, body composition, and high-density lipoprotein cholesterol (HDL-C). Short-chain triacylglycerols emerged as a distinctive, consistently elevated SevO signature.

PMID:
42898103
Bibliographic data and abstract were imported from PubMed on 20 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 19
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement